Section Arrow
Quote
AMPH.NASDAQ
- Amphastar Pharmaceuticals
Quotes are at least 15-min delayed:2024/09/21 01:07 EDT
Last
 49.18
-0.91 (-1.82%)
Day High 
50.615 
Prev. Close
50.09 
1-M High
50.61 
Volume 
990.07K 
Bid
48
Ask
51
Day Low
48.94 
Open
50.46 
1-M Low
43.6 
Market Cap 
2.45B 
Currency USD 
P/E 15.9 
%Yield -- 
10-SMA 47.09 
20-SMA 47.41 
50-SMA 44.16 
52-W High 65.9249 
52-W Low 36.56 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
3.15/--
Enterprise Value
3.07B
Balance Sheet
Book Value Per Share
14.57
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
644.40M
Operating Revenue Per Share
7.52
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
VTRSViatris11.39-0.51-4.29%227.2PE
TLRYTilray Brands1.71-0.07-3.93%-- 
TEVATeva Pharmaceutical Industries Limited17.51-0.25-1.41%-- 
ELANElanco Animal Health14.07-1-6.64%-- 
IRWDIronwood Pharmaceuticals4.305-0.205-4.55%56.38PE
Quotes are at least 15-min delayed：2024/09/21 01:07 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has tworeportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.